Search for: "In re Transkaryotic Therapies, Inc."
Results 1 - 20
of 22
Sort by Relevance
|
Sort by Date
22 Apr 2018, 7:06 pm
See In re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
5 Feb 2016, 8:25 am
Transkaryotic Therapies, Inc., 346 F.3d 1094 (Fed. [read post]
20 Feb 2015, 10:14 am
In In re Appraisal of Transkaryotic Therapies, Inc., 2007 WL 1378345 (Del. [read post]
29 Jan 2015, 6:02 am
The findings follow the analysis applied in In Re Appraisal of Transkaryotic Therapies, Inc., a 2007 case which preceded an amendment to Section 262(e) later that year permitting beneficial owners to petition for appraisal in their own name. [read post]
15 Oct 2011, 12:12 pm
In re Alloy, Inc. [read post]
17 May 2010, 4:42 am
See In Re Transkaryotic Therapies, Inc., 954 A.2d 346, 360-61 (Del. [read post]
19 Mar 2010, 8:00 am
§ 262; see also In re Appraisal of Transkaryotic Therapies, Inc., 2007 Del. [read post]
18 Mar 2010, 5:00 am
See In re Appraisal of Transkaryotic Therapies, Inc., 2007 Del. [read post]
29 Jul 2009, 9:03 am
” (citing In Re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
22 Jan 2009, 8:01 am
McDonald (In re World Health Alternatives, Inc.), 385 B.R. 576 (Bankr. [read post]
3 Jan 2009, 5:15 am
#3 In re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
31 Dec 2008, 9:00 am
In re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
31 Oct 2008, 12:15 pm
See In re Netsmart Techs., Inc. [read post]
22 Jul 2008, 12:27 pm
Duty Of Disclosure: Delaware Chancellor Further Limits Availability of Damages From Travis Laster: Recently, Delaware Chancellor Chandler - in In re Transkaryotic Therapies, Inc. - granted summary judgment in favor of three directors who were alleged to have breached their fiduciary duties by supporting and voting in favor of the acquisition of Transkaryotic Therapies by Shire Pharmaceuticals. [read post]
25 Jun 2008, 12:03 pm
Duty Of Disclosure: Delaware Chancellor Further Limits Availability of Damages From Travis Laster: Last week, Delaware Chancellor Chandler - in In re Transkaryotic Therapies, Inc. - granted summary judgment in favor of three directors who were alleged to have breached their fiduciary duties by supporting and voting in favor of the acquisition of Transkaryotic Therapies by Shire Pharmaceuticals. [read post]
19 Jun 2008, 3:35 pm
In re Transkaryotic Therapies, Inc., C.A. 2776-CC (Del Ch. [read post]
29 Nov 2007, 5:15 am
See In re: Appraisal of Transkaryotic Therapies, Inc., 2007 Del. [read post]
16 May 2007, 7:26 am
More on Appraisal Rights and Transkaryotic Therapies In response to last week's blog on Chancellor Chandler's opinion in In re: Appraisal of Transkaryotic Therapies, Inc., an anonymous member weighed in: "By describing DTC as essentially a black box stuffed with... [read post]
10 May 2007, 7:03 am
Appraisal Rights: Delaware Chancellor Weighs In From Travis Laster: Last week, in In re: Appraisal of Transkaryotic Therapies, Inc., Chancellor Chandler of the Delaware Court of Chancery addressed a technical issue under the appraisal statute that has important implications for... [read post]
8 May 2007, 10:51 am
In re: Appraisal of Transkaryotic Therapies, Inc. [read post]
